Gene · 81
Papers2,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| One-year longitudinal study of the stratum corneum proteome of retinol and all-trans-retinoic acid treated human skin: an orchestrated molecular event. | Sci Rep | 2023 | 37433822 | PubTator, text mining | PubMed |
| Extracellular vesicle-associated tyrosine kinase-like orphan receptors ROR1 and ROR2 promote breast cancer progression. | Cell Commun Signal | 2023 | 37430307 | PubTator, text mining | PubMed |
Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis. | Front Immunol | 2023 | 37426643 | PubTator, text mining | PubMed |
| Proteomic profile of uninvolved versus crescentic glomeruli in MPO-ANCA-associated vasculitis. | Clin Kidney J | 2023 | 37398696 | PubTator, text mining | PubMed |
| The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma. | Int J Mol Sci | 2023 | 37373484 | PubTator, text mining | PubMed |
| Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study. | Blood | 2023 | 37369098 | PubTator, text mining | PubMed |
| Induction of filopodia formation by α-Actinin-2 via RelA with a feedforward activation loop promoting overt bone marrow metastasis of gastric cancer. | J Transl Med | 2023 | 37337244 | PubTator, text mining | PubMed |
| A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer. | BMC Med Genomics | 2023 | 37337170 | PubTator, text mining | PubMed |
| Deciphering the molecular mechanism of enhanced tumor activity of the EGFR variant T790M/L858R using melanoma cell lines. | Front Oncol | 2023 | 37333807 | PubTator, text mining | PubMed |
| Identification and assessment of novel dynamic biomarkers for monitoring non-traumatic osteonecrosis of the femoral head staging. | Clin Transl Med | 2023 | 37313692 | PubTator, text mining | PubMed |
| Genetic Risk Factors Associated With Preeclampsia and Hypertensive Disorders of Pregnancy. | JAMA Cardiol | 2023 | 37285119 | PubTator, text mining | PubMed |
| Sjögren's syndrome: novel insights from proteomics and miRNA expression analysis. | Front Immunol | 2023 | 37275849 | PubTator, text mining | PubMed |
| Antagonistic interactions among structured domains in the multivalent Bicc1-ANKS3-ANKS6 protein network govern phase transitioning of target mRNAs. | iScience | 2023 | 37275520 | PubTator, text mining | PubMed |
| Angiopoietin-like protein 3: a novel potential biomarker for nephrotic syndrome in children. | Front Pediatr | 2023 | 37266537 | PubTator, text mining | PubMed |
| Nsp14 of SARS-CoV-2 inhibits mRNA processing and nuclear export by targeting the nuclear cap-binding complex. | Nucleic Acids Res | 2023 | 37260089 | PubTator, text mining | PubMed |
| Exploration of the immunogenetic landscape of hyperprogressive disease after combined immunotherapy in cancer patients. | iScience | 2023 | 37255657 | PubTator, text mining | PubMed |
| Gene knockout inference with variational graph autoencoder learning single-cell gene regulatory networks. | Nucleic Acids Res | 2023 | 37246643 | PubTator, text mining | PubMed |
| Impairment of rigidity sensing caused by mutant TP53 gain of function in osteosarcoma. | Bone Res | 2023 | 37246175 | PubTator, text mining | PubMed |
| Copy number gain of ACTN4 is associated with poor prognosis in patients with upper urinary tract urothelial carcinoma. | Cancer Sci | 2023 | 37226638 | PubTator, text mining | PubMed |
| The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway. | Front Oncol | 2023 | 37207150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81/papers?page=12